• BTC $8,238.86 (-0.19%)
  • ETH $175.40 (0.26%)
  • MARKET CAP $227B
  • ICOs 4,245

Open Longevity

ENDED 333 views
6.5
Total Rate

A new project in the field of biotechnology, telemedicine, clinical research and medical services is completing preparations for pre-ICO. Open Longevity is being developed to organize research on aging therapies in humans through the provision of advisory services to users. The ultimate goal is to find and introduce effective methods of radical life extension into clinical practice. Therefore, our tokens are called YEAR. Creating a platform, we combine the capabilities of modern IT-systems, the expertise of leading scientific analysts and the concernment of the patients themselves—members of Open Longevity community and future users of our online platform. It is important to note another driving force of the project—its openness and rejection of commercial benefits in those matters where this can affect the objectivity of scientific research. We are sure that effective ways to delay the onset of old age will be found—it is only a matter of time. Open Longevity wants to accelerate scientific research by involving a large number of people in clinical trials of aging therapies and creating an online platform for people to monitor health status, receive necessary recommendations from gerontologists, nutritionists and physicians to form a personal strategy for improving and preserving health.
General
Website: Visit
White paper: Read
ICO Time: 10 Oct, 2017 - 10 Dec, 2017
Country: Russia
Token Info
Ticker: YEAR
Platform: Ethereum
Token type: ERC20
Financial
Pre-sale Price: 100 USD = 1300 - 2000 YEAR
ICO Price: 100 USD = 1000 - 1500 YEAR
Accepting: ETH
Soft cap: 7,500,000 USD
Hard cap: 35,500,000 USD
Social Media
  • 1

    Starting Q1 2018

    Platform: The server part of the platform, API, allocation; Implementing YEAR; Patient card; Collection of markers, analyzes and images; Diagnostic panels; Data statistics; Access to foreign laboratories; Testing + QA. Diagnostics: Creating and interpreting new panels; Introduction of new panels. Text-based consultations. CI. Launch of the first Longevity Diet study.

  • 2

    Starting Q2 2018

    Platform: Integration with laboratories (data acquisition without input); Development of iOS and Android applications; Integration with Gadgets; Customizable interface. Marketplace: Creating a platform. Diagnostics: BigData analytics; Text and image interpretation. Consultations: Communication with voice.

  • 3

    Starting Q3 2018

    Platform: Loading external databases. Marketplace: Creating an API. CI: Creation of a platform for conducting CI. Consultations: Video consulting.

  • 4

    Starting Q4 2018

    Platfrom: Integration with medical cards. Consultations: Rating system for doctors. CI: Voting system YEAR; Matching, selection of participants for CI; Launch the second study.

  • 5

    Starting Q1 2019

    Platform: Development of an external API platform. Diagnostics: Creating a neural network.

  • 6

    Starting Q2 2019

    Platform: Implementing ZeroX. Diagnostics: Neaural network + PubMed; Predictors of geroprotectors; Neuronet + DNA; Neural network + Images.

  • 7

    Starting Q4 2019

    Platform: Social network. CI: Launch of third study.

Stepan Habardin

Senior digital designer

Elena Karyagina

IR

Ilya Kleshnin

PR

Sergey Kobelev

CIO

Ivan Shmidik

PR

Nikolay Sidorov

PR и GR

Anastasia Egorova

ED

Mikhail Batin

CEO

Roman Makarov

Senior developer

Put this code to your website

Width: 420px-Height: 210px
comments powered by Disqus
Hot and trending ICOs
This website is using cookies. More info.